Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design, synthesis, and in vitro and in vivo characterization of new memantine analogs for Alzheimer's disease
Andreea L. Turcu, Júlia Companys‐Alemany, Matthew B. Phillips, et al.
European Journal of Medicinal Chemistry (2022) Vol. 236, pp. 114354-114354
Open Access | Times Cited: 19

Showing 19 citing articles:

Deuterium in drug discovery: progress, opportunities and challenges
Rita Maria Concetta Di Martino, Brad D. Maxwell, Tracey Pirali
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 7, pp. 562-584
Open Access | Times Cited: 234
Advances in Alzheimer's disease: A multifaceted review of potential therapies and diagnostic techniques for early detection
Monika Sharma, Pankaj Pal, Sukesh Kumar Gupta
Neurochemistry International (2024) Vol. 177, pp. 105761-105761
Closed Access | Times Cited: 15
Unraveling the role of chitosan for nasal drug delivery systems: A review
Gurjeet Kaur, Jayant Goyal, Prabhat Kumar Behera, et al.
Carbohydrate Polymer Technologies and Applications (2023) Vol. 5, pp. 100316-100316
Open Access | Times Cited: 16
NMDA receptor antagonists reduce amyloid-β deposition by modulating calpain-1 signaling and autophagy, rescuing cognitive impairment in 5XFAD mice
Júlia Companys‐Alemany, Andreea L. Turcu, Marion Schneider, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 8
Open Access | Times Cited: 26
Glial cell reactivity and oxidative stress prevention in Alzheimer’s disease mice model by an optimized NMDA receptor antagonist
Júlia Companys‐Alemany, Andreea L. Turcu, Santiago Vázquez, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 19
Adverse event profile of memantine and donepezil combination therapy: a real-world pharmacovigilance analysis based on FDA adverse event reporting system (FAERS) data from 2004 to 2023
Yihan Yang, Sheng Wei, Huan Tian, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Recent Advances in Therapeutics for the Treatment of Alzheimer’s Disease
Amin Mahmood Thawabteh, Aseel Wasel Ghanem, Sara AbuMadi, et al.
Molecules (2024) Vol. 29, Iss. 21, pp. 5131-5131
Open Access | Times Cited: 4
Targeting CaN/NFAT in Alzheimer’s brain degeneration
Joanna Mackiewicz, Malwina Lisek, Tomasz Boczek
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 10
Calcium Modulating Effect of Polycyclic Cages: A Suitable Therapeutic Approach Against Excitotoxic-induced Neurodegeneration
Ayodeji O. Egunlusi, Sarel F. Malan, Vitalii A. Palchykov, et al.
Mini-Reviews in Medicinal Chemistry (2024) Vol. 24, Iss. 13, pp. 1277-1292
Closed Access | Times Cited: 2
Design, synthesis, biological evaluation, and molecular modeling simulations of new phthalazine‐1,4‐dione derivatives as anti‐Alzheimer's agents
Demokrat Nuha, Asaf Evrim Evren, Begüm Nurpelin Sağlık, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 10
Open Access | Times Cited: 1
ZA-II-05, a novel NMDA-receptor antagonist reverses vanadium-induced neurotoxicity in Caenorhabditis elegans (C. elegans)
Amany Digal Ladagu, Funmilayo Eniola Olopade, Paul L. Chazot, et al.
BMC Neuroscience (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Triple-mode sensing platform for acetylcholinesterase activity monitoring and anti-Alzheimer’s drug screening based on a highly stable Cu (I) compound
Yongkang Cai, Yue Li, Yuanyuan Wang, et al.
Biosensors and Bioelectronics (2024) Vol. 271, pp. 117078-117078
Closed Access | Times Cited: 1
Synthesis, Neuroprotective Effect and Physicochemical Studies of Novel Peptide and Nootropic Analogues of Alzheimer Disease Drug
Radoslav Chayrov, Тatyana V. Volkova, German L. Perlovich, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 9, pp. 1108-1108
Open Access | Times Cited: 5
The Structural Characteristics of Compounds Interacting with the Amantadine-Sensitive Drug Transport System at the Inner Blood–Retinal Barrier
Yusuke Shinozaki, Yuma Tega, Shin‐ichi Akanuma, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 3, pp. 435-435
Open Access | Times Cited: 2
Synthesis of novel thiosemicarbazone derivatives and investigation of their dual AChE and MAO‐B inhibitor effects
Ayşe Nur Uytun, Derya Osmani̇ye, Begüm Nurpelin Sağlık, et al.
Journal of Molecular Recognition (2022) Vol. 35, Iss. 12
Closed Access | Times Cited: 3
Gene Regulation by Nuclear Calcium and Its Antagonism by NMDAR/TRPM4 Signaling
Priit Pruunsild, C. Peter Bengtson, Jing Yan, et al.
(2024), pp. 113-170
Closed Access
Recent Advances in the Search for Effective Anti-Alzheimer’s Drugs
Martyna Ogos, Dorota Stary, Marek Bajda
International Journal of Molecular Sciences (2024) Vol. 26, Iss. 1, pp. 157-157
Open Access
Optimized N-methyl-D-aspartate receptor antagonist exhibits hippocampal proneurogenic effects in aged senescence-accelerated mouse prone 8 mice
Júlia Companys‐Alemany, Joan Roig-Soriano, Andreea L. Turcu, et al.
Neuroreport (2022) Vol. 33, Iss. 14, pp. 623-628
Open Access | Times Cited: 1
Memantine-Based Derivatives: Synthesis and Their Biological Evaluation
Vinod Kumar, Vijay Kumar, Naveen Kumar, et al.
(2023), pp. 185-209
Closed Access
Page 1

Scroll to top